Opioid Rehab Near You: MAT, Detox & Recovery Programs
Browse SAMHSA-listed opioid rehab programs across all 50 states — filter by MAT type (buprenorphine, methadone, naltrexone), level of care (OTP, OBOT, residential, IOP, telehealth), and insurance acceptance. MAT reduces opioid overdose deaths by more than 50% (NIDA), yet fewer than 20% of people with OUD receive it. Synthetic opioids (primarily fentanyl) drive ~75% of US opioid overdose deaths — CDC reports over 80,000 annually. After the 2023 MAT Act, any licensed prescriber can offer buprenorphine in office-based or telehealth settings.
Found 9,319 rehab centers specializing in opioid addiction across the United States.
Need Help Finding the Right Treatment Center?
Speak with a compassionate specialist now - 100% free & confidential
Find Opioid Treatment Centers Near You
Browse opioid treatment centers below. Filter by MAT availability, state, insurance, and level of care to find the right program for your recovery needs.
Showing 20 of 9319 results
MacNeal Hospital in Berwyn, IL is dedicated to providing extensive addiction treatment for individuals, both adults and young adults, who are dealing with substance use disorders and overlapping mental health issues. The center offers a range of services including hospital-based inpatient detox, intensive outpatient programs, and round-the-clock hospital inpatient care. Employing methods like 12-step facilitation, cognitive behavioral therapy, and brief intervention, the facility customizes treatment plans to suit each person's unique requirements. Their specialized programs are designed for individuals with co-occurring disorders, guaranteeing comprehensive care. Prioritizing high standards and individualized treatment, MacNeal Hospital accepts both male and female patients, fostering a nurturing atmosphere for healing and recovery.
Madison East Comprehensive Treatment Center, located in Madison, WI, provides a variety of outpatient services focused on detoxification and treating substance use disorders. The center offers outpatient detox services alongside treatment options using methadone, buprenorphine, or naltrexone. By employing techniques such as brief intervention, cognitive behavioral therapy, and motivational interviewing, the center supports active military personnel as well as adult men and women. Catering to both adults and young adults of all genders, Madison East Comprehensive Treatment Center is dedicated to delivering customized care aimed at guiding individuals towards successful recovery with an emphasis on quality and efficacy.
Madison West Comprehensive Trt Ctr, located in Madison, WI, specializes in extensive outpatient treatment for substance use disorders. The center offers options such as methadone/buprenorphine and naltrexone outpatient treatment, standard outpatient services, and focused programs for individuals dealing with both mental health issues and substance use, including those who are pregnant or postpartum. Catering to adults and young adults of all genders, Madison West emphasizes personalized care by employing strategies like anger management, motivational interviewing, and techniques for preventing relapse. The facility is dedicated to providing high-quality, individualized support to assist clients in their recovery journey with empathy and evidence-based methods.
Madrona Recovery, located in Portland, OR, delivers an extensive array of services to those pursuing recovery from addiction. This center specializes in care for detoxification, treatment of substance use disorders, and co-occurring mental health issues for both adults and minors. It features residential detox options, around-the-clock residential care, as well as short-stay programs. Emphasizing 12-step approaches, anger management, and quick intervention techniques, Madrona Recovery personalizes treatment strategies to fit each individual's circumstances. The center stands out with its distinct offerings for teenagers, individuals who have experienced intimate partner violence, domestic abuse, and sexual trauma. Madrona Recovery admits clients of all genders, including children and teens, ensuring inclusive and quality support for every age group.
Magnolia Medical Group, located in Denver, CO, delivers focused outpatient care for adults grappling with substance use issues and concurrently facing severe mental health challenges, as well as addressing significant emotional issues in children. This center features customized treatment plans that encompass outpatient services for methadone/buprenorphine or naltrexone, cognitive behavioral therapy, motivational interviewing, and strategies for preventing relapse. With particular attention to the needs of pregnant and postpartum women, Magnolia Medical Group serves individuals of all genders, including young adults. Its commitment to high-quality care and personalized treatment makes it a leading option for those in the Denver community seeking extensive addiction recovery services.
The MN Adult and Teen Challenge located in Duluth, MN, presents an extensive array of rehabilitation services designed for adult men and women, young adults, and individuals facing both mental health and substance use challenges. This center offers a variety of services including detoxification, substance abuse treatment, transitional housing, and sober living facilities. Treatment options encompass intensive outpatient, outpatient, and day treatment programs. The center utilizes methods such as 12-step facilitation, anger management, and brief interventions. MN Adult and Teen Challenge is particularly focused on assisting those who have endured trauma, promoting a comprehensive approach to healing. With a commitment to high-quality care and personalized treatment strategies, this establishment aims to guide clients toward achieving lasting sobriety.
MPower Wellness of Pennsylvania LLC, located in Exton, PA, delivers robust programs for substance abuse and specialized support for those facing concurrent mental health and addiction challenges. The facility features intensive outpatient services, day treatment options, and partial hospitalization for adults and young adults. Their approach incorporates 12-step facilitation, anger management techniques, and brief intervention strategies, specifically addressing trauma survivors and individuals with dual diagnoses. MPower Wellness of Pennsylvania LLC provides gender-inclusive, high-quality care to aid individuals in their path toward lasting recovery.
Situated in Cliffside Park, NJ, MMM Health Services Inc presents a wide array of treatment solutions for substance use issues. This center is adept at addressing co-occurring substance use disorders as well as significant mental health conditions in adults, and emotional challenges in children. The facility offers various programs including intensive outpatient therapy, outpatient day treatment, and partial hospitalization. MMM Health Services Inc employs evidence-based methodologies such as 12-step facilitation, anger management strategies, and cognitive behavioral therapy. With specialized programs designed for active military members and both adult men and women, the center is committed to providing exceptional care and assistance to individuals of all ages and backgrounds on their path to recovery.
Magnolia Medical Group located in Wheat Ridge, CO, specializes in outpatient treatment for adults dealing with substance use disorders alongside severe mental health challenges, as well as treatment for children facing significant emotional difficulties. The facility offers outpatient options including methadone/buprenorphine or naltrexone therapies, cognitive behavioral therapy, motivational interviewing, and strategies for preventing relapse. There are specific programs designed for pregnant and postpartum women. Catering to both adult and young adult clients, the center provides personalized care for individuals regardless of gender. With its comprehensive and specialized services, it stands out as an excellent option for those in need of effective rehabilitation solutions in the Wheat Ridge community.
Madeline Centre in Lynchburg, Virginia, treats children, adolescents, adults, and seniors through partial hospitalization, intensive outpatient, and regular outpatient programs, with buprenorphine available. Groups served include veterans, forensic clients, and trauma survivors. Medicaid and private insurance are accepted, and a sliding fee scale and payment assistance are offered.
Short-term residential substance use treatment in Pulaski, TN, for adult women and men, with programming for veterans, active duty military, military families, and criminal justice clients. Naltrexone is used in treatment. Payment options include TRICARE, private health insurance, and cash or self-payment.
Part of Alta Bates Summit Medical Center in Oakland, California, MPI Treatment Services runs hospital inpatient detoxification, residential detox and short-term residential care, plus partial hospitalization and intensive outpatient programs. Buprenorphine and naltrexone are used in treatment. Sign language services are available, and TRICARE, private insurance, and self-pay are accepted.
Situated in Shreveport, LA, Magnolia Recovery presents a wide array of treatment programs for substance use aimed at both adults and youth, including those who face significant mental health challenges or emotional issues. The center focuses on intensive outpatient services, outpatient treatment, and medication-assisted options using methadone, buprenorphine, or naltrexone. Emphasizing therapies such as anger management, cognitive behavioral therapy, and the Matrix Model, this facility is designed to meet the specific requirements of active duty military personnel, young people, and adult males. Magnolia Recovery provides inclusive services for both genders, dedicated to delivering effective and compassionate support to those seeking recovery from addiction.
Exton, Pennsylvania, is served by MVP Recovery Inc, which provides intensive and regular outpatient treatment with buprenorphine and naltrexone for children, adolescents, adults, and seniors, including care for co-occurring serious mental illness. Medicaid, private insurance, and federal funding are accepted, with services in Spanish and sign language.
The Macoupin County Public Health Department, situated in Gillespie, IL, offers outpatient care for individuals, both adults and young adults, who are dealing with substance use disorders and co-occurring mental health issues. This center provides several treatment avenues, including medication-assisted treatment with methadone, buprenorphine, or naltrexone, alongside standard outpatient services. Employing proven methods like cognitive behavioral therapy and contingency management, the program emphasizes personalized recovery plans for all clients, regardless of gender. Their dedication to effective treatment and high standards makes them a strong choice for those pursuing recovery from addiction and mental health concerns.
The Macoupin County Public Health Dept in Carlinville, IL provides extensive rehabilitation programs. This clinic focuses on addiction recovery for adults and adolescents, particularly those facing dual diagnoses such as significant mental health challenges or emotional disorders. Services include outpatient care, such as medication-assisted treatment with methadone, buprenorphine, or naltrexone, alongside consistent outpatient counseling. Emphasizing personalized support, the facility offers interventions like anger management, brief counseling, and cognitive behavioral therapy. Their tailored treatment strategies are designed to support both male and female individuals on their journey to recovery and improved health.
The Macoupin County Public Health Dept located in Litchfield, IL, provides extensive outpatient services for individuals grappling with substance use issues and related mental health challenges. The center features specialized programs designed to meet the unique needs of both adults and children, including anger management, brief interventions, and cognitive behavioral approaches. Offering access to outpatient options such as methadone, buprenorphine, or naltrexone treatment, alongside regular outpatient support, they emphasize a comprehensive recovery strategy. Catering to individuals of all genders, this facility is committed to delivering high-quality care through tailored treatment plans. For those in need of effective, evidence-supported rehabilitation, this center is focused on aiding you in achieving sustainable recovery.
Situated in Marshall, NC, the Madison County Health Department delivers extensive support for substance use disorders through its outpatient services. The center specializes in the administration of methadone, buprenorphine, and naltrexone treatments, employing motivational interviewing techniques to assist clients on their path to recovery. This facility is designed for adult men and women, including those who have faced intimate partner violence or domestic abuse. Catering to all genders, the center fosters a secure and welcoming atmosphere for individuals pursuing addiction treatment. Committed to high-quality care and proven methods, the Madison County Health Department aims to help individuals attain sustainable recovery.
Children, adolescents, and adults in West Chester, Pennsylvania, receive outpatient and intensive outpatient treatment at MVP Recovery LLC, including buprenorphine and naltrexone and care for co-occurring emotional disturbance in children and serious mental illness in adults. Medicaid, private insurance, and federal funding are accepted, with sign language services.
MVP Recovery LLC in Media, Pennsylvania, provides day treatment or partial hospitalization, intensive outpatient, and regular outpatient substance use care with buprenorphine and naltrexone for children, adolescents, adults, and seniors. Medicaid, private insurance, and federal government funding for substance use treatment programs are accepted.
Opioid Use Disorder (OUD): Key Facts
Classification
Opioid Use Disorder (OUD)
Prevalence
2.1 million adults with OUD in the US (SAMHSA)
Overdose deaths
80,000+ opioid overdose deaths/year in US (CDC)
Primary substances
Fentanyl, heroin, oxycodone, hydrocodone
Gold standard treatment
Medication-Assisted Treatment (MAT)
MAT effectiveness
Reduces overdose deaths by 50%+ (NIDA)
FDA-approved medications
Buprenorphine (Suboxone), Methadone, Naltrexone (Vivitrol)
Emergency reversal
Naloxone (Narcan)
Opioid Overdose Emergency: Know the Signs
An opioid overdose can kill within minutes. If you see these signs, act immediately:
Overdose warning signs
- Blue or purple lips and fingernails (cyanosis)
- Pinpoint (extremely small) pupils
- Slow, shallow, or stopped breathing
- Unresponsive to shouting or sternal rub
- Gurgling or choking sounds
- Limp body, pale or clammy skin
What to do
- Call 911 immediately — most states have Good Samaritan laws protecting callers
- Administer naloxone (Narcan) if available — nasal spray or injection
- Perform rescue breathing — one breath every 5 seconds
- Place in recovery position (on their side) to prevent choking
- Give a second dose of naloxone after 2-3 minutes if no response
- Stay until help arrives — naloxone wears off in 30-90 minutes
National Overdose Prevention Hotline: 911 | SAMHSA Helpline: 1-800-662-4357 (24/7, free, confidential)
What Is Opioid Use Disorder?
DSM-5 diagnostic criteria
Opioid Use Disorder (OUD) is a chronic, relapsing brain condition defined by the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5). It is diagnosed when a person meets at least two of eleven criteria within a 12-month period, including: taking opioids in larger amounts or for longer than intended, persistent desire or unsuccessful efforts to cut down, spending excessive time obtaining or using opioids, cravings, failure to fulfill major obligations, continued use despite social or interpersonal problems, giving up important activities, use in physically hazardous situations, continued use despite physical or psychological problems, tolerance, and withdrawal.
Severity classification
OUD severity is classified based on the number of criteria met: mild (2-3 criteria), moderate (4-5 criteria), and severe (6 or more criteria). Severe OUD carries the highest risk of overdose death and typically requires the most intensive treatment, including medication-assisted treatment. Even mild OUD warrants professional intervention, as the disorder tends to progress without treatment.
Opioids vs. opiates
The term "opiates" refers specifically to natural compounds derived from the opium poppy (morphine, codeine). "Opioids" is the broader term that includes opiates plus semi-synthetic drugs (oxycodone, hydrocodone, heroin) and fully synthetic drugs (fentanyl, methadone, tramadol). All opioids bind to mu-opioid receptors in the brain, producing pain relief, euphoria, and respiratory depression — the mechanism that causes fatal overdoses.
The Opioid Epidemic: Fentanyl Crisis
Three waves of the opioid epidemic
The US opioid crisis has unfolded in three distinct waves. The first wave (1990s) was driven by aggressive marketing of prescription opioids — OxyContin, Vicodin, Percocet — leading doctors to overprescribe and millions of patients to develop dependence. The second wave (around 2010) saw a surge in heroin use as people with prescription opioid addiction shifted to cheaper, more accessible heroin. The third wave (2013-present) is defined by illicitly manufactured fentanyl and its analogs, which now account for the majority of opioid overdose deaths in the United States.
Why fentanyl changed everything
Fentanyl is a fully synthetic opioid that is 50-100 times more potent than morphine and approximately 50 times more potent than heroin. A lethal dose of fentanyl is just 2 milligrams — roughly the size of a few grains of salt. Because fentanyl is cheap to manufacture and extremely potent by weight, drug traffickers mix it into heroin, cocaine, methamphetamine, and counterfeit prescription pills. Many people who die from fentanyl overdoses did not know they were consuming it. Counterfeit pills made to look like oxycodone (M30), Xanax, or Adderall frequently contain lethal doses of fentanyl.
Current impact
According to the CDC, over 80,000 Americans die from opioid overdoses each year, with synthetic opioids (primarily illicit fentanyl) responsible for roughly 75% of those deaths. Opioid overdose is now the leading cause of accidental death for Americans under 50. The crisis affects every demographic, geographic region, and socioeconomic group in the country.
Opioid Withdrawal Timeline
Opioid withdrawal is intensely uncomfortable but rarely life-threatening on its own. The timeline varies depending on whether the person was using short-acting opioids (heroin, oxycodone, hydrocodone) or long-acting opioids (methadone, extended-release morphine).
Short-acting opioids (heroin, oxycodone)
- 6-12 hours: Onset of symptoms — anxiety, muscle aches, sweating, yawning, runny nose
- 24-48 hours: Escalation — insomnia, diarrhea, nausea, vomiting, abdominal cramps, dilated pupils
- 48-72 hours: Peak severity — intense cravings, body aches, goosebumps, rapid heartbeat
- 5-7 days: Acute symptoms begin to subside
- 1-2 weeks: Most physical symptoms resolve
Long-acting opioids (methadone, ER morphine)
- 24-48 hours: Delayed onset of symptoms
- 3-5 days: Symptoms escalate and peak
- 5-10 days: Peak and plateau of acute withdrawal
- 10-20 days: Gradual improvement of physical symptoms
- 2-3 weeks: Most acute symptoms resolve
Post-Acute Withdrawal Syndrome (PAWS)
After acute withdrawal resolves, many people experience Post-Acute Withdrawal Syndrome (PAWS) — a set of prolonged symptoms including anxiety, depression, insomnia, fatigue, difficulty concentrating, and mood swings that can persist for weeks to months. PAWS is the leading cause of relapse in the first year of recovery and is a key reason why ongoing treatment and support are essential after detox.
Why medical detox matters
While opioid withdrawal itself is rarely fatal, the extreme discomfort drives many people to relapse during detox — and relapse after a period of abstinence is when overdose risk is highest, because tolerance has decreased. Medically supervised detoxification uses medications like buprenorphine, clonidine, and comfort medications to manage symptoms safely, dramatically reducing relapse during the withdrawal period.
Medication-Assisted Treatment (MAT)
Medication-Assisted Treatment is the gold standard for opioid use disorder, combining FDA-approved medications with counseling and behavioral therapies. Research from NIDA shows MAT reduces opioid overdose deaths by more than 50%, decreases illicit opioid use, reduces criminal activity, improves social functioning, and increases treatment retention. Despite this evidence, fewer than 20% of people with OUD receive MAT — a treatment gap that costs tens of thousands of lives each year.
Buprenorphine (Suboxone)
Type: Partial opioid agonist
Buprenorphine activates opioid receptors just enough to prevent withdrawal and cravings without producing the intense euphoria of full agonists. It has a "ceiling effect," meaning higher doses do not increase effects — significantly reducing overdose risk. Suboxone combines buprenorphine with naloxone to deter misuse.
Setting: Can be prescribed by any licensed prescriber in office-based settings (OBOT), pharmacies, or telehealth.
Methadone
Type: Full opioid agonist
Methadone is a long-acting opioid that stabilizes brain chemistry, eliminates withdrawal symptoms, and blocks the euphoric effects of other opioids at proper doses. It has the longest track record of any MAT medication, with over 50 years of evidence supporting its effectiveness.
Setting: Must be dispensed daily at a certified Opioid Treatment Program (OTP/methadone clinic). Take-home doses earned over time with compliance.
Naltrexone (Vivitrol)
Type: Opioid antagonist (blocker)
Naltrexone completely blocks opioid receptors, preventing any opioid from producing effects. The extended-release injection (Vivitrol) is administered monthly and eliminates the need for daily medication adherence. Unlike buprenorphine and methadone, naltrexone has no abuse potential and is not a controlled substance.
Requirement: Patient must be fully detoxed (7-14 days opioid-free) before starting naltrexone to avoid precipitated withdrawal.
MAT medication comparison
The three FDA-approved MAT medications differ in mechanism, dispensing model, and patient fit. The table below summarizes the key distinctions:
| Medication | Type | DEA Schedule | Setting | Dispensing | Best for |
|---|---|---|---|---|---|
| Buprenorphine (Suboxone, Sublocade, Subutex, Zubsolv, Brixadi) | Partial agonist with ceiling effect | III | OBOT, telehealth, retail pharmacy | Take-home from day 1 (or monthly injection) | Most patients; rural areas; daily clinic not feasible |
| Methadone | Full mu-opioid agonist | II | OTP only (42 CFR Part 8) | Daily at clinic → take-home after 90 days | Severe OUD; prior buprenorphine failure; long-standing dependence |
| Naltrexone (Vivitrol) | Opioid antagonist (blocker) | Not controlled | Any prescriber; injection at clinic | Monthly IM injection (380 mg) | Highly motivated; post-detox (7-14 days opioid-free); no abuse potential desired |
All three are effective; the best choice is the one the patient will actually take consistently. Adherence, not pharmacology, is the dominant predictor of outcomes. Buprenorphine and methadone are first-line for active opioid use; naltrexone requires complete detox before initiation.
Types of Opioid Treatment Programs
OTP / Methadone Clinics
Opioid Treatment Programs are federally certified clinics that dispense methadone and provide comprehensive services including counseling, drug testing, and case management. Patients visit daily initially, earning take-home privileges over time.
OBOT (Office-Based Treatment)
Office-Based Opioid Treatment allows any licensed prescriber to treat OUD with buprenorphine in a standard medical office or via telehealth. This model dramatically increases access, especially in rural areas with no OTPs. Patients fill prescriptions at regular pharmacies.
Residential (inpatient) programs provide 24/7 structured care for 30-90 days. Best for severe OUD, polysubstance use, co-occurring mental health disorders, or patients who need separation from their environment. Most residential programs offer MAT as part of treatment.
IOP programs provide 9-20 hours of structured treatment per week while allowing patients to live at home. Combines group therapy, individual counseling, and MAT. Effective for moderate OUD or as a step-down from residential treatment.
Standard outpatient involves 1-2 sessions per week — typically individual therapy and/or group sessions combined with MAT. Suitable for mild to moderate OUD or as a long-term maintenance level of care after completing more intensive treatment.
Medical detox provides 3-7 days of supervised withdrawal management using medications to ease symptoms. Detox alone is not treatment — it must be followed by ongoing MAT and/or behavioral therapy. Detox without continued care has very high relapse rates.
Naloxone: The Overdose Reversal Medication
What naloxone does
Naloxone (brand name Narcan) is an opioid antagonist that rapidly reverses opioid overdose by displacing opioids from receptors in the brain. It restores normal breathing within 2-5 minutes in most cases. Naloxone has no effect on people who do not have opioids in their system and has virtually no abuse potential. Since 2023, Narcan nasal spray is available over the counter at pharmacies nationwide without a prescription.
How to use naloxone nasal spray
Using Narcan nasal spray requires no medical training:
- Peel back the package and remove the device
- Tilt the person's head back and insert the nozzle into one nostril
- Press the plunger firmly to deliver the full dose
- If no response in 2-3 minutes, administer a second dose in the other nostril
- Continue rescue breathing and call 911 — naloxone wears off in 30-90 minutes, and the person may stop breathing again
Where to get naloxone for free
Many harm reduction organizations, health departments, and community pharmacies distribute naloxone for free or at low cost. SAMHSA's Opioid Overdose Prevention Toolkit and state naloxone access programs provide resources. Most states have standing orders allowing pharmacists to dispense naloxone without an individual prescription. If you or someone you know uses opioids, carrying naloxone can save a life.
Frequently Asked Questions About Opioid Treatment
What is medication-assisted treatment (MAT) for opioid addiction?
Medication-Assisted Treatment (MAT) combines FDA-approved medications — methadone, buprenorphine (Suboxone), or naltrexone (Vivitrol) — with counseling and behavioral therapies. These medications reduce cravings, prevent withdrawal symptoms, and normalize brain chemistry, allowing people to focus on recovery. MAT is the most effective treatment for opioid use disorder: it reduces overdose deaths by more than 50%, decreases illicit drug use, and improves treatment retention rates (NIDA).
How long does opioid withdrawal last?
The withdrawal timeline depends on the opioid used. Short-acting opioids like heroin and oxycodone cause symptoms within 6-12 hours that peak at 48-72 hours and subside over 5-7 days. Long-acting opioids like methadone produce delayed symptoms starting at 24-48 hours, peaking at 3-5 days, and lasting up to 2-3 weeks. Post-acute withdrawal symptoms (PAWS) — including anxiety, insomnia, and mood instability — may persist for weeks to months after acute withdrawal resolves.
Is buprenorphine (Suboxone) just replacing one addiction with another?
No — this is one of the most harmful misconceptions in addiction medicine. Buprenorphine is a partial opioid agonist prescribed at stable, controlled doses as part of comprehensive treatment. It does not produce euphoria when taken as directed, eliminates cravings, prevents withdrawal, and allows people to function normally — work, care for families, and rebuild their lives. Taking buprenorphine for OUD is no different than taking insulin for diabetes: it is evidence-based medication for a chronic medical condition.
What should I look for in an opioid treatment center?
Look for centers offering MAT options (buprenorphine, methadone, and/or naltrexone), accreditation from CARF or The Joint Commission, licensed medical staff experienced in addiction medicine, comprehensive assessment with individualized treatment plans, evidence-based therapies (CBT, contingency management), family support services, and strong aftercare planning. Verify they accept your insurance and offer the appropriate level of care for your situation.
Can I work while in opioid treatment?
Yes, especially with outpatient MAT programs. Outpatient treatment — including OBOT (office-based buprenorphine) and standard outpatient counseling — allows you to maintain work, family, and social responsibilities while receiving care. Intensive Outpatient Programs (IOP) typically meet 9-20 hours per week and can often be scheduled around work. Many employers are required to support recovery under the ADA and FMLA. Residential treatment requires time away but provides the most intensive support for severe cases.
What is fentanyl and why is it so dangerous?
Fentanyl is a fully synthetic opioid that is 50-100 times more potent than morphine. A lethal dose is just 2 milligrams. It is increasingly found in the illicit drug supply, mixed into heroin, cocaine, methamphetamine, and counterfeit prescription pills — often without the user's knowledge. Fentanyl is now responsible for roughly 75% of all opioid overdose deaths in the United States. Treatment for fentanyl addiction typically requires MAT (often at higher buprenorphine or methadone doses), naloxone training, and comprehensive behavioral support.
How long does MAT treatment last?
There is no fixed duration for MAT — treatment length should be individualized. Research consistently shows that longer treatment produces better outcomes. The American Society of Addiction Medicine (ASAM) recommends a minimum of one year of MAT, and many addiction specialists recommend indefinite maintenance for people with severe OUD, as the risk of fatal overdose is highest in the period after discontinuing MAT. The decision to taper off medication should be made collaboratively with a treatment provider when the patient is stable, has strong support systems, and is not facing major life stressors.
Is fentanyl in the drug supply near me?
Almost certainly yes. Fentanyl has been detected in the illicit drug supply in all 50 states. It is routinely found in heroin, counterfeit prescription pills (especially fake oxycodone M30s, Xanax, and Adderall), cocaine, and methamphetamine. DEA lab testing shows that 7 out of 10 counterfeit pills seized contain a potentially lethal dose of fentanyl. Fentanyl test strips — which can detect fentanyl before use — are available for free from many harm reduction organizations, health departments, and community pharmacies. The safest assumption is that any illicit substance may contain fentanyl.
Medical Review and Sources
Trusted Resources
Substance Abuse and Mental Health Services Administration
Federal agency providing information, resources, and treatment locator for substance abuse and mental health.
Helpline: 1-800-662-4357
National Institute on Drug Abuse
NIH institute advancing science on drug use and addiction causes, consequences, and treatment.
National Institute on Alcohol Abuse and Alcoholism
NIH institute supporting research on alcohol's impact on health and providing treatment resources.
Ready To Start Opioid Treatment?
Opioid addiction is a medical condition — not a moral failure. Medication-assisted treatment saves lives. Speak with a specialist who can help you find the right MAT program, detox center, or residential facility — 100% free and confidential, available 24/7.
Browse opioid addiction programs in states with the most treatment options.
Related conditions, treatment approaches, and levels of care.